Skip to main content
. 2022 Feb 24;13(2):135–146. doi: 10.5306/wjco.v13.i2.135

Figure 3.

Figure 3

Percentage of mutations in the most common breast cancer associated genes in breast cancers with and without neurotrophic receptor tyrosine kinase amplifications. Data are from TCGA breast cancer cohort. Black columns: Neurotrophic receptor tyrosine kinase amplified; Grey columns: Neurotrophic receptor tyrosine kinase non-amplified.